| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 01/27/1999 | EP0892791A1 Substituted benzenesulfonamide derivatives as prodrugs of cox-2 inhibitors |
| 01/27/1999 | EP0892790A1 New quinazoline-4-amino-2-(piperidine-1-yl-4-substituted) derivatives having anti-hypertensive activity, a method for their preparation and their pharmaceutical use |
| 01/27/1999 | EP0892789A1 Irreversible inhibitors of tyrosine kinases |
| 01/27/1999 | EP0892644A1 $i(IN VIVO) GENE TRANSFER METHODS FOR WOUND HEALING |
| 01/27/1999 | EP0892643A1 Methods for inhibiting an immune response by blocking the gp39/cd40 and ctla4/cd28/b7 pathways and compositions for use therewith |
| 01/27/1999 | EP0892642A1 Use in a composition of an extract of at least one labiate |
| 01/27/1999 | EP0892633A2 Use of inhibitors of the activity of retinoic acid for treating sensitive skin and/or acute damage induced by uv radiation |
| 01/27/1999 | EP0731792B1 Heterocyclic benzenesulfonylimine derivatives as inhibitors of il-1 action |
| 01/27/1999 | EP0669919B1 Use of dimethylbenzofurans and dimethylbenzopyrans as 5-ht3 antagonists |
| 01/27/1999 | EP0658198B1 Multicistronic expression units and their use |
| 01/27/1999 | CN1206422A Growth-hormone secretagogues |
| 01/27/1999 | CN1206417A 1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives |
| 01/27/1999 | CN1206414A N-acyl-2-substituted-4-(benzimidazolyl-or imidazopyridinyl-substituted pesidues)-piperidines as tachykinin antagonists |
| 01/27/1999 | CN1206411A Thiol derivatives with metallopeptidase inhibitory activity |
| 01/27/1999 | CN1206406A 1-(1,2-disubstituted piperidinyl)-4-substituted piperidine derivatives as tachykinin receptor antagonists |
| 01/27/1999 | CN1206405A Imides as PDE III, PDE IV and TNF inhibitors |
| 01/27/1999 | CN1206349A Pharmaceutical composition comprising plant worms and muirapuama |
| 01/27/1999 | CN1206010A 5H-thiazole [3,2-a] pyrimidine derivatives |
| 01/27/1999 | CN1206005A Novel inhibitors of bone reabsorption and antagonists of vitronectin receptors |
| 01/27/1999 | CN1041830C Peptide compound |
| 01/27/1999 | CN1041797C Tablets with improved bioavailability of active material clodronic acid |
| 01/27/1999 | CN1041794C Stabilized pharmaceutical composition comprising an. HMG-COA reductase inhibitor compound |
| 01/26/1999 | US5864045 Antiasthmatics, treatment of cough, bronchitis |
| 01/26/1999 | US5864037 Dethionating, halogenating and aminating a 2-thiocarbonyl-6-oxo-3,8-disubstituted-1,2,3,6-tetrahydro-3h-purine to obtain the 6-amino derivative; bronchodilators; antiinflammatory agents |
| 01/26/1999 | US5864036 Substituted imidazole compounds |
| 01/26/1999 | US5864024 Synthetic glycoamines and methods for their use that affect cell adhesion, inhibit cancer cell metastasis, and induce apoptosis |
| 01/26/1999 | US5864021 Method and apparatus for the production of TGF-β and purified TGF-β compositions |
| 01/26/1999 | US5863949 Reacting carboxylic acid derivative with 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide, 1-hydroxybenzenetriazole and hydroxylamine; treats diseases involving production of tumor necrosis factor in a mammal |
| 01/26/1999 | US5863942 Retinoid conjugate compounds useful for the treatment of aging skin |
| 01/26/1999 | US5863935 Synthesis of indole derivatives of heterocyclic compounds for treatment of headaches and migraines |
| 01/26/1999 | US5863934 Use of lofexidine in the treatment of behavioral disorders |
| 01/26/1999 | US5863931 Amidino derivatives and their use as nitric oxide synthase inhibitors |
| 01/26/1999 | US5863927 Dextromethorphan and an oxidase inhibitor for treating intractable conditions |
| 01/26/1999 | US5863926 4,4-(disubstituted)cyclohexan-1-carboxylate monomers and related compounds |
| 01/26/1999 | US5863923 Treatment of anxiety, psychosis, schizophrenia, drug abuse, irritable bowel syndrome |
| 01/26/1999 | US5863921 Purine and guanine derivatives |
| 01/26/1999 | US5863918 Naphthalene derivatives |
| 01/26/1999 | US5863916 8-aza, 6-aza and 6,8-diaza-1,4-dihydroquinoxaline-2,3-diones and the use thereof as antagonists for the glycine/NMDA receptor |
| 01/26/1999 | US5863913 Aromatic compound and pharmaceutical composition |
| 01/26/1999 | US5863901 Use of bradykinin antagonists for the production of pharmaceuticals for the treatment of chronic fibrogenetic liver disorders and acute liver disorders |
| 01/26/1999 | US5863900 Lhrh antagonists |
| 01/26/1999 | US5863892 Use of platelet derived growth factor in ophthalmic wound healing |
| 01/26/1999 | US5863889 ICAM-1/LFA-1 short-chain peptides and method of using same |
| 01/26/1999 | US5863795 Nucleic acids that encode peptides which modulate apoptosis |
| 01/26/1999 | US5863780 A polynucleotide sequence encodes human protein kinase polypeptide; culture product |
| 01/26/1999 | US5863767 Keratinocyte growth factor fragment lacks the first 23 amino acid residues of the n-terminus of mature, full-length kgf; treatment of hyperproliferative disease of epidermis |
| 01/26/1999 | US5863537 Polypeptide comprising a variable region having the amino acid sequence of the variable region selected from the group consisting of h25d2h-1, h25d2h-2, h25d2h-3, h25d2h-4 and h25d2h-5 |
| 01/26/1999 | CA2166692C Novel 9-n-bicyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines |
| 01/26/1999 | CA2132829C Novel derivatives of 2,3-dihydro-benzofuranols |
| 01/26/1999 | CA2000786C 3-piperidinyl-1,2-benzisoxazoles |
| 01/25/1999 | CA2238664A1 Novel regulator |
| 01/23/1999 | CA2238611A1 Novel lyss |
| 01/23/1999 | CA2238608A1 Novel cyss |
| 01/21/1999 | WO1999002713A1 Pseudomonas exotoxin a-like chimeric immunogens |
| 01/21/1999 | WO1999002711A2 Fusion proteins with an immunoglobulin hinge region linker |
| 01/21/1999 | WO1999002694A1 Nucleic acid sequence and method for selectively expressing a protein in a target cell or tissue |
| 01/21/1999 | WO1999002681A1 Erbb4 receptor-specific neuregulin, related ligands and uses thereof |
| 01/21/1999 | WO1999002680A1 New human growth regulator protein |
| 01/21/1999 | WO1999002678A1 Wa545 compositions |
| 01/21/1999 | WO1999002674A1 Peptides containing the motif igd and their use as cell migration modulators |
| 01/21/1999 | WO1999002654A1 Isolation of bone and cartilage precursor cells |
| 01/21/1999 | WO1999002556A1 Semaphorin receptors |
| 01/21/1999 | WO1999002550A1 Ctl epitopes from ebv |
| 01/21/1999 | WO1999002548A1 A preparation derived from shark cartilage for treatment of diseases related to excessive phf or excessive intracellular calcium |
| 01/21/1999 | WO1999002547A1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases |
| 01/21/1999 | WO1999002526A1 Tropane analogs and methods for inhibition of monoamine transport |
| 01/21/1999 | WO1999002519A1 4,5-DIHYDRO-[1H]-BENZ[g]INDAZOLE-3-CARBOXYLIC ACID DERIVATIVES |
| 01/21/1999 | WO1999002517A1 6-pyrrolidin-2-ylpyrindine derivatives, their preparation and application in therapy |
| 01/21/1999 | WO1999002514A2 Epothilone derivatives |
| 01/21/1999 | WO1999002510A1 Matrix metalloproteinase inhibitors |
| 01/21/1999 | WO1999002506A1 5-(3-phenyl-3-oxo-propyl)-1h-tetrazole derivatives |
| 01/21/1999 | WO1999002505A1 Il-5 inhibiting 6-azauracil derivatives |
| 01/21/1999 | WO1999002504A1 6-azauracil derivatives as il-5 inhibitors |
| 01/21/1999 | WO1999002503A1 Triazole compounds and the use thereof as dopamine-d3-ligands |
| 01/21/1999 | WO1999002501A1 Novel compounds |
| 01/21/1999 | WO1999002497A2 Pyridine derivatives |
| 01/21/1999 | WO1999002496A1 (+)-norcisapride useful for 5-ht3 and 5-ht4 mediated disorders |
| 01/21/1999 | WO1999002494A1 Gastrokinetic monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives |
| 01/21/1999 | WO1999002479A1 Method for producing calcium pyruvates |
| 01/21/1999 | WO1999002191A1 Compositions and methods for enhancing delivery of therapeutic agents to cells |
| 01/21/1999 | WO1999002181A1 Use of hyaluronidase in the manufacturing of a drug for the treatment of inflammation |
| 01/21/1999 | WO1999002178A1 Therapeutic agent for the treatment of septicaemia, its preparation and use |
| 01/21/1999 | WO1999002170A1 Absorption of minerals by intestinal cells |
| 01/21/1999 | WO1999002167A1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF raf GENE EXPRESSION |
| 01/21/1999 | WO1999002166A1 Use of colchinol derivatives as vascular damaging agents |
| 01/21/1999 | WO1999002163A1 Inhibitors of neutrophil mediated oxidant production |
| 01/21/1999 | WO1999002162A1 Cyclin dependent kinase inhibiting purine derivatives |
| 01/21/1999 | WO1999002156A1 Gastrokinetic bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivates |
| 01/21/1999 | WO1999002155A1 Imidazole derivatives as mdr modulators |
| 01/21/1999 | WO1999002143A2 Medicament comprising adenosine |
| 01/21/1999 | WO1999002142A2 Novel composition comprising an ssri and a beta-blocker |
| 01/21/1999 | WO1998048025A3 Regulatory system for inducible expression of genes with lambdoid promoters |
| 01/21/1999 | WO1998031389A3 Fibronectin binding protein compositions, antibodies thereto, and methods of use |
| 01/21/1999 | WO1998024810A3 Vertebrate homologues of unc-53 protein of c. elegans |
| 01/21/1999 | DE19730989A1 Piperazin-Derivate Piperazine derivatives |
| 01/21/1999 | CA2297187A1 Tropane analogs and methods for inhibition of monoamine transport |
| 01/21/1999 | CA2296581A1 Use of hyaluronidase in the manufacturing of a drug for the treatment of inflammation |
| 01/21/1999 | CA2296440A1 5-(3-phenyl-3-oxo-propyl)-1h-tetrazole derivatives |
| 01/21/1999 | CA2296102A1 Triazole compounds and the use thereof as dopamine-d3-ligands |
| 01/21/1999 | CA2296037A1 4,5-dihydro-¬1h|-benz¬g|indazole-3-carboxylic acid derivatives |